Inventor · disambiguated record
Youzhen Wang
Also filed as: WANG YOUZHEN
3 granted patents·14 pending applications·106 citations·filing 2002–2019
67Inventor score
Top patents by PatentIndex Score
17 records- 0192US7705120B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Granted Apr 27, 2010·106 cites·24 claims
- 0271US2010105051A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0365US2008311573A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 0460US8906936B2Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereofNOVARTIS AG·Filed 2013·Granted Dec 9, 2014·0 cites·6 claims
- 0560US2021386763A1Pharmaceutical combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0658US2011092388A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 0757US2009005411A1Combinations of Organic CompoundsNOVARTIC AG·Filed 2006·Application pending·0 cites
- 0856US10507201B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2019·Granted Dec 17, 2019·0 cites·17 claims
- 0953US2013085153A1Combination of an iap inhibitor and a taxane for the treatment of a proliferative diseaseJENSEN MICHAEL RUGAARD·Filed 2012·Application pending·0 cites
- 1052US2010324083A1Combinations of Organic CompoundsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 1148US2021121460A1A triple pharmaceutical combination comprising dabrafenib, trametinib and an erk inhibitorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1246US2018185341A1Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1345US2022016118A1Combination of a mcl-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereofSERVIER LAB·Filed 2019·Application pending·0 cites
- 1439US2014314784A1Anti-cxcr4 antibodies and methods of useBEDIAN VAHE·Filed 2012·Application pending·0 cites
- 1538US2003215805A1Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1637US2003099974A1Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1730US2019240225A1Combination of a bcl-2 inhibitor and a mcl-1 inhibitor, uses and pharmaceutical compositions thereofSERVIER LAB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Youzhen Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →